About us

Our company is founded on a passion for pioneering advancements in vaccine development.


Our Mission

We develop innovative vaccines for a healthier world.

Our Vision

We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.

Our Approach

We leverage our proprietary ExpreS2 protein expression system, employing insect cells to synthesize proteins essential for vaccine development. Our methodology involves prudent selection of pertinent antigens, engineering of the antigens for optimal expression in the ExpreS2 system, and rigorous implementation of quality control protocols.

Our strategy is geared towards accelerating the development of drug candidates with short timelines and cost-effective paths to value creation.

Team

Our team has more than 100 years of experience relevant to drug development and is committed to developing innovative vaccines for the world’s worst infectious diseases and cancer, channeling their expertise and passion into pioneering advancements.



Executive Management

Bent U. Frandsen

Chief Executive Officer

Keith Alexander

Chief Financial Officer

Dr. Farshad Guirakhoo

Chief Scientific Officer

Dr. Max M. Søgaard

Senior Vice President of R&D and Technology

Board of Directors

Dr. Martin Roland Jensen

Chairman

Dr. Karin Garre

Board Member

Jakob Knudsen

Board Member

Sara Sande

Board Member

Advisory Boards

ExpreS2ion Biotechnologies boasts two distinguished scientific advisory boards: the Oncology Scientific Advisory Board and the Infectious Diseases Scientific Advisory Board.

These expert panels contribute invaluable insights, guiding the company’s research and development efforts in cancer and infectious disease vaccines, respectively. Their collective expertise enhances ExpreS2ion’s strategic decision-making and supports cutting-edge advancements in these critical fields.

Advisory Board - Infectious Diseases

Dr. Stanley Plotkin

MD, PhD, DMSci

Dr. Allan Randrup Thomsen

MD, DMSci

Dr. Lone Graff Stensballe

MD, PhD, DMSci

Dr. Mark Schleiss

MD

Advisory Board - Oncology

Dr. Giuseppe Curigliano

MD, PhD

Dr. Javier Cortes

MD, PhD

Dr. Ulrik Lassen

MD, PhD

Dr. Michael Andersson

MD, DMSci

Dr. Rupert Bartsch

MD

Dr. Daniel Lenihan

MD, FACC, FESC, FIC-OS